Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human FGF13 ELISA Kit (AC3710)
Cat.#: ASET-2299
Specifications
Description Human FGF13 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human FGF13 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.04 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 50-800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2055 Mouse Glutamine Synthetase ELISA Kit (AC3466) Quantitative inquiry ASET-2028 Mouse Has2 ELISA Kit (AC3439) Quantitative inquiry ASET-1166 Human LRP5 ELISA Kit (AC2577) Quantitative inquiry ASET-1452 Mouse Cannabinoid Receptor II ELISA Kit (AC2863) Quantitative inquiry ASET-1254 Human SHP2 ELISA Kit (AC2665) Quantitative inquiry ASET-2061 Rat NF-kB p65 ELISA Kit (AC3472) Quantitative inquiry ASET-1531 Human PSD95 ELISA Kit (AC2942) Quantitative inquiry ASET-1457 Human Neurogranin ELISA Kit (AC2868) Quantitative inquiry ASET-1715 Mouse CaMKII beta ELISA Kit (AC3126) Quantitative inquiry ASET-2050 Human MAL ELISA Kit (AC3461) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket